Turkish Competition Authority initiated a formal antitrust investigation against pharma giants, Roche and Novartis. The Authority aims to investigate the claims that Novartis and Roche has violated antitrust rules by promoting and increasing the use of the more expensive ophthalmology drug, Lucentis instead of Altuzan.
(Board Decision - 13.06.2019, 19-21/307-M)
If there is need of any other information about the article, please contact the below stated person.
|
NAZALI ANTITRUST |